CJC-1295
growth-hormone
Verified
A growth hormone releasing hormone (GHRH) analog that stimulates growth hormone release.
Chemical Information
Source:
Synthetic peptide produced via solid-phase peptide synthesis.
Clinical Information
Purposes:
Increase GH production
Improve body composition
Enhance sleep quality
Dosing:
Typical dosing is 1000-2000mcg per week, divided into daily or every-other-day injections.
Related Peptides:
Ipamorelin
GHRP-2
GHRP-6
Safety Information
Side Effects:
- Water retention
- Headache
- Temporary numbness at injection site
- Increased insulin resistance
Contraindications:
- Active malignancy
- Uncontrolled diabetes
- Pregnancy or breastfeeding
Research & References
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805.
- https://pubmed.ncbi.nlm.nih.gov/16352683/
Last updated: 3/28/2025 at 5:16:27 AM
Version: 1
Detailed Information
Purposes
Increase GH production
Improve body composition
Enhance sleep quality
Related Peptides
Ipamorelin
GHRP-2
GHRP-6
Source Information
Synthetic peptide produced via solid-phase peptide synthesis.
Last updated: March 28, 2025
Version: 1